Detalles de la búsqueda
1.
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
BMC Psychiatry
; 24(1): 175, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433233
2.
Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand.
Aust N Z J Psychiatry
; : 48674241242315, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561896
3.
Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.
Med J Aust
; 219(5): 218-226, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449648
4.
A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
Australas Psychiatry
; 31(3): 329-335, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753675
5.
Tobacco dependence management in a smoke-free inpatient drug and alcohol unit.
Australas Psychiatry
; 29(1): 14-21, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301381
6.
Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids.
Australas Psychiatry
; 27(1): 80-85, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30298754
7.
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
BMC Psychiatry
; 18(1): 140, 2018 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29776349
8.
The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) - a case report.
Australas Psychiatry
; 29(6): 707, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014788
9.
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia.
J Addict Med
; 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38828937
10.
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial.
Am J Psychiatry
; 181(5): 403-411, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706338
11.
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Int J Drug Policy
; 127: 104390, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38522175
12.
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
Int J Drug Policy
; 128: 104468, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795465
13.
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019.
Drug Alcohol Rev
; 42(2): 389-400, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36524444
14.
The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls.
Addiction
; 117(6): 1589-1597, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34817096
15.
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Subst Abuse Treat Prev Policy
; 17(1): 67, 2022 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209081
16.
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
Drug Alcohol Depend
; 234: 109388, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316689
17.
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
Int J Drug Policy
; 110: 103876, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240657
18.
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.
Int J Drug Policy
; 100: 103492, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736130
19.
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Int J Drug Policy
; 105: 103706, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35533635
20.
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Viruses
; 14(7)2022 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891535